Experimental Alzheimer's drug shows promise targeting brain protein tau in study

Experimental Alzheimer's drug shows promise targeting brain protein tau in study
FacebookXWhatsAppEmail

An experimental drug might help slow early Alzheimer’s disease in a markedly different way than today’s treatments — by lowering levels of a brain protein called tau, researchers reported Tuesday. Tau is one part of a toxic duo fueling Alzheimer’s but prior attempts to develop drugs that can t...